Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literatureLazaros J Lekakis, Amber Lawson, Jeanette Prante, et al.
The American Journal of the Medical Sciences|December 17, 2009
Long-term complete regression of nodal marginal zone lymphoma transformed into diffuse large B-cell lymphoma with highly active antiretroviral therapy alone in human immunodeficiency virus infectionIoannis G Baraboutis, Leonidas Marinos, Lazaros J Lekakis, et al.
Mycopathologia|June 24, 2018
Invasive Rhinosinusitis Caused by Lasiodiplodia theobromae in an Allogeneic Hematopoietic Cell Transplant Recipient Case Report and Review of LiteratureAnamaria Rodriguez, Shweta Anjan, Octavio V Martinez, et al.
Blood|March 16, 2025
Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 StudyMatthew J Frigault, Richard T Maziarz, Jae H Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsYi-Bin Chen, Yvonne A Efebera, Laura Johnston, et al.
Blood|July 18, 2025
RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCTZachariah DeFilipp, Hannah K Choe, Yvonne A Efebera, et al.
Cureus|July 3, 2026
Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center ExperienceJoseph I Berger, Anthony D Anderson, Octavio V Martinez, et al.
Blood Advances|October 9, 2020
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphomaFrederick L Locke, John M Rossi, Sattva S Neelapu, et al.
The Lancet. Haematology|December 11, 2024
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trialJuan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, et al.
Transplantation and Cellular Therapy|August 26, 2024
Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell LymphomaFrederick L Locke, Sattva S Neelapu, Nancy L Bartlett, et al.
Pageof 4